These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 3180062)

  • 1. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
    Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors.
    Perrot-Applanat M; Groyer-Picard MT; Lorenzo F; Jolivet A; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
    Cancer Res; 1987 May; 47(10):2652-61. PubMed ID: 2436753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers.
    Perrot-Applanat M; Groyer-Picard MT; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
    Am J Pathol; 1989 Sep; 135(3):457-68. PubMed ID: 2675623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor.
    Press MF; Greene GL
    Endocrinology; 1988 Mar; 122(3):1165-75. PubMed ID: 3342750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
    Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptor analyses of nine human breast cancer cell lines.
    Horwitz KB; Zava DT; Thilagar AK; Jensen EM; McGuire WL
    Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor.
    Blankenstein MA; Berns PM; Blaauw G; Mulder E; Thijssen JH
    Cancer Res; 1986 Aug; 46(8 Suppl):4268s-4270s. PubMed ID: 3731090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line.
    Graham ML; Dalquist KE; Horwitz KB
    Cancer Res; 1989 Jul; 49(14):3943-9. PubMed ID: 2660983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
    Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
    Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
    Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
    Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of fine needle aspirates in the evaluation of progesterone receptor content in breast cancer.
    Lozowski M; Greene GL; Sadri D; Stanick D; Pai P; Harris MA; Lundy J
    Acta Cytol; 1990; 34(1):27-30. PubMed ID: 2404374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium.
    King RJ; Coffer AI; Gilbert J; Lewis K; Nash R; Millis R; Raju S; Taylor RW
    Cancer Res; 1985 Nov; 45(11 Pt 2):5728-33. PubMed ID: 2413995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines.
    Graham ML; Bunn PA; Jewett PB; Gonzalez-Aller C; Horwitz KB
    Cancer Res; 1989 Jul; 49(14):3934-42. PubMed ID: 2736533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.
    King WJ; DeSombre ER; Jensen EV; Greene GL
    Cancer Res; 1985 Jan; 45(1):293-304. PubMed ID: 3965140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand.
    Press MF; Xu SH; Wang JD; Greene GL
    Am J Pathol; 1989 Nov; 135(5):857-64. PubMed ID: 2683797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer.
    Hendler FJ; Yuan D
    Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.